glp-1 resources Medications – Community Education Your patient is losing weight

FOXO4-DRI (also known as Proxofim) is a synthetic peptide with a retro-inverso structure, developed by Dutch researchers as a modified version of the FOXO4 protein with an extended half-life

Its difficult to distinguish direct anti-inflammatory effects from the benefits of weight loss and improved metabolic health, but the pattern is consistent enough to warrant further study. A 2025 study found that RA patients with a BMI over 27 taking GLP-1 medications showed improvements in symptoms and disease activity

Medications like semaglutide (Wegovy) and liraglutide (Saxenda) are among the leading prescription drugs that help patients achieve significant weight loss

Conclusion In summary, proper storage of Mounjaro is crucial for ensuring its efficacy and your overall health management